Skip to main content

Table 2 Model inputs

From: Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis

Parameters

Base case value

Range tested (%)

Unit drug costs (RMB)

 Unit cost of docetaxel (cost per mg)

73.62

± 20

 Unit cost of abiraterone (cost per mg)

0.58

± 20

 Unit cost of prednisolone/prednisone (cost per mg)

1.33

± 20

Dosage

 Daily dosage of docetaxel (mg/m2)

75

± 20

 Daily dosage of abiraterone (mg)

1000

± 20

 Daily dosage of prednisolone (mg)

5

± 20

 Average height (m)

1.615

± 20

 Average weight (kg)

61.8

± 20

Other medical costs (RMB)

 Hospitalisation costs for chemotherapy

318

± 20

 Preventive drugs for chemotherapy

620

± 20

 ADT cost per month

2050

± 20

 Laboratory test costs

500

± 20

 Inpatient OOP 

15

± 20

 Outpatient OOP %

25%

± 20

Costs of adverse events (RMB)

 Hypertension

98.70

± 50

 Hypokalaemia

65.00

± 50

 ALT increased

225.68

± 50

 Hyperglycaemia

115.00

± 50

 AST increased

225.68

± 50

 Bone pain

583.00

± 50

 Cardiac disorder

1000.00

± 50

 Anaemia

271.70

± 50

 Back pain

73.60

± 50

 Spinal-cord compression

1235.00

± 50

 Fatigue

540.44

± 50

 Allergic reaction

75.00

± 50

 Diarrhoea

31.44

± 50

 Stomatitis

74.00

± 50

 Neuropathy

375.84

± 50

 Thromboembolism

1794.20

± 50

 Sudden death

3200.00

± 50

 Thrombocytopenia

3518.04

± 50

 Neutropaenia

720.80

± 50

 Febrile neutropaenia

1787.20

± 50

 Infection with neutropaenia

14,764.05

± 50